Day: June 7, 2022

$26M Estate in Southampton Now Available for Sale on Gin Lane

233 Gin Lane Southampton Aerial SOUTHAMPTON, N.Y., June 07, 2022 (GLOBE NEWSWIRE) — With easy access to the historic village’s Main Street and Job Lane, which features fine restaurants, designer boutiques and fine-art galleries, summers in Southampton are what memories are made of. Just 90 minutes from New York City,

Philips announces exchange ratio for 2021 dividend

June 7, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that the exchange ratio for the dividend in shares for the year 2021 has been determined. The exchange ratio is 1 new common share for every 27.3184 existing common shares. This ratio was based on

Trust Payments partners with Feedzai to strengthen risk management offerings

LONDON and AMSTERDAM, June 07, 2022 (GLOBE NEWSWIRE) — Trust Payments, the disruptive leader in fintech specialising in frictionless payments and value-added services, announced today at Money20/20 Europe a multi-year partnership with Feedzai, the world’s first RiskOps platform for financial risk management. Using Feedzai, a key market leader in safeguarding

Willem Appelo to succeed Sophie Bechu as Philips’ Chief Operations Officer

June 7, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Willem (Wim) Appelo will join Philips’ Executive Committee, effective July 18, 2022, and succeed Sophie Bechu as Chief Operations Officer per October 1, 2022. Mr. Appelo will report to Philips CEO Frans van […]

crop.zone Secures USD 11 Million Equity Funding

Keeping an eye on the world market: crop.zone strengthens its capital base for serial production Dirk Vandenhirtz CEO – Founder AACHEN, Germany, June 07, 2022 (GLOBE NEWSWIRE) — Good news for herbicide-free agriculture. crop.zone, manufacturer of the volt.fuel Electrical Weeding System, has significantly strengthened its capital base for entering into

MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis

GHENT, Belgium, June 07, 2022 (GLOBE NEWSWIRE) — MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announces the publication of preclinical research relating to its ongoing program in non-alcoholic fatty liver disease (NAFLD), with a 9-strain live bacterial consortium resulting from its proprietary and unique CORAL®